(M+) Merck: Kai Beckmann to Become New Ceo After Belén Garijo's Resignation
Summary by Manager Magazin
1 Articles
1 Articles
After five years at the helm of the pharmaceutical and chemical multinational Merck, Belén Garijo will step down in 2026. The owners are likely to choose a 59-year-old veteran as the successor to the DAX-listed CEO. His starting conditions could be better.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium